Discontinuation report APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE
Report ID | 177953 |
Drug Identification Number | 02416255 |
Brand name | APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE |
Common or Proper name | ZIDOVUDINE LAMIVUDINE ABACAVIR |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | ZIDOVUDINE LAMIVUDINE ABACAVIR |
Strength(s) | 300MG 150MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 BTL |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-12-02 |
Remaining supply date | 2018-12-03 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-12-12 | French | Compare |
v1 | 2022-12-12 | English | Compare |
Showing 1 to 2 of 2